subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEBI:32660

subject_name: asparaginase

object_name: T-Cell Lymphoma

tested_intervention: unsure


subject: CHEBI:32660

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: cocaine abuse

tested_intervention: yes


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: stage II adult soft tissue sarcoma


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Asperger syndrome


subject: CHEBI:91512

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:91512

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:3628

subject_name: homoharringtonine


subject: PUBCHEM.COMPOUND:3628


subject: CHEBI:71019

subject_name: omacetaxine


subject: CHEBI:71019


subject: UNII:66226JUH2I

subject_name: ONALESPIB LACTATE

object_name: Non-small cell lung cancer recurrent


subject: UNII:66226JUH2I

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C4330853

subject_name: Onalespib Lactate


subject: UMLS:C4330853


subject: UNII:6ZJ8V3Q0H1


subject: MESH:C000627796

subject_name: Nano-PSO

object_name: LSD abuse


subject: UMLS:C3256645

subject_name: pomegranate seed oil


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:9150

object_name: Carcinoma breast stage IV


subject: CHEBI:9150

object_name: malignant neoplasm of breast stage IV


subject: UMLS:C1436082

object_name: epilepsy


subject: CHEBI:46295

subject_name: Vardenafil

object_name: coronary microvascular disorder


subject: CHEBI:46295

object_name: type 2 diabetes mellitus


subject: CHEBI:29865

subject_name: benzo[a]pyrene

object_name: type 1 diabetes mellitus


subject: CHEBI:29865

object_name: diabetes mellitus


subject: CHEBI:29865

object_name: type 1 diabetes mellitus 1


subject: PR:000000281

subject_name: growth/differentiation factor 5


subject: PR:000000281


subject: PR:000000281


subject: UMLS:C4529885

subject_name: Fiasp


subject: UMLS:C4529885


subject: UMLS:C4529885


subject: UMLS:C2095775

subject_name: ampicillins

object_name: dystonia


subject: CHEBI:28971

subject_name: Ampicillin


subject: UNII:MRL3739G66

subject_name: Dotatate


subject: CHEBI:55340

subject_name: morphine hydrochloride

object_name: Acute Pain


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: Primary squamous cell carcinoma of anal canal


subject: UNII:2Y3T5IF01Z

object_name: anal canal squamous cell carcinoma


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: CHEBI:17895

subject_name: Tyrosine

object_name: Parkinson disease


subject: UNII:DSS3BE2ZXN

subject_name: tusamitamab ravtansine

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C3896771


subject: UMLS:C1828979

subject_name: Theramine

object_name: Knee pain


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Alcoholic Intoxication


subject: CHEBI:7465

object_name: alcohol consumption (history)


subject: CHEBI:7465

object_name: alcohol-induced disorders


subject: CHEBI:50629

subject_name: cyclooxygenase 2 inhibitor

object_name: bile duct carcinoma


subject: CHEBI:50629

object_name: bile duct cancer


subject: CHEBI:50629

object_name: cholangiocarcinoma


subject: CHEBI:50629

object_name: pancreatic neoplasm


subject: CHEBI:50629

object_name: exocrine pancreatic carcinoma


subject: CHEBI:50629

object_name: malignant pancreatic neoplasm


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: UMLS:C3884209

object_name: type 1 diabetes mellitus


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL2109465

object_name: Atopic rhinitis


subject: CHEMBL.COMPOUND:CHEMBL2109465

object_name: Allergic Rhinitis, CTCAE


subject: UNII:871QYF3I7B

subject_name: MILK PROTEIN CONCENTRATE

object_name: Amino acid change


subject: UNII:871QYF3I7B

object_name: Nutritional status


subject: UNII:871QYF3I7B

object_name: microtia


subject: CHEBI:47612

subject_name: Bezafibrate

object_name: bipolar disorder


subject: CHEBI:47612

object_name: Depressed mood


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: hypoglycemia


subject: UMLS:C3714501

object_name: Blood glucose below reference range (finding)


subject: UMLS:C3714501

object_name: Hypoglycemia, CTCAE


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:5931


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: acquired hemophilia A


subject: UMLS:C0295415

subject_name: rituximab


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:5281767

object_name: metabolic syndrome X


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: Childhood Solid Neoplasm


subject: UNII:CJN36EQM0H

object_name: Adult Solid Neoplasm


subject: UNII:CJN36EQM0H

object_name: Solid Neoplasm


subject: UNII:CJN36EQM0H

object_name: HER2 gene amplification


subject: UNII:CJN36EQM0H

object_name: ERBB2 Gene Mutation


subject: UNII:CJN36EQM0H

object_name: HER2 protein overexpression


subject: UNII:VYR5R5XN5A

subject_name: LUNSEKIMIG

object_name: atopic eczema


subject: UMLS:C5909039

subject_name: Lunsekimig


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: hyperglycemia


subject: PUBCHEM.COMPOUND:11306691

object_name: Hyperglycemia, CTCAE


subject: PUBCHEM.COMPOUND:11306691

object_name: Glucose in blood specimen above reference range


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:40237


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: granulomatosis with polyangiitis


subject: UNII:I031V2H011

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: CHEBI:71200

subject_name: Tofacitinib


subject: CHEBI:71200


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: adult lymphoma


subject: CHEBI:79699

object_name: lymphoma


subject: CHEBI:79699

object_name: pediatric lymphoma


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J

object_name: Metastatic non-small cell lung cancer


subject: UNII:PQX0D8J21J

object_name: Advanced Lung Carcinoma


subject: UNII:PQX0D8J21J

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Adult Solid Neoplasm


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:44915

subject_name: Propofol

object_name: childhood acute lymphoblastic leukemia


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: Endotracheal aspiration


subject: UMLS:C0016004

object_name: Aspiration, CTCAE


subject: UMLS:C0016004

object_name: Aspiration


subject: UMLS:C0016004

object_name: Seroma, CTCAE


subject: UMLS:C0016004

object_name: Seroma


subject: UMLS:C0016004

object_name: Childhood Breast Carcinoma


subject: UMLS:C0016004

object_name: breast carcinoma


subject: UMLS:C0016004

object_name: breast cancer


subject: CHEBI:8863

subject_name: Riluzole

object_name: post-traumatic stress disorder


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: osteoarthritis


subject: CHEBI:64356

subject_name: Pregabalin


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: metastatic colorectal cancer


subject: UMLS:C3896806


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: progeria


subject: UMLS:C4018803

subject_name: Antisense Oligonucleotide [EPC]

object_name: progressive supranuclear palsy


subject: PUBCHEM.COMPOUND:4479094

subject_name: Doxercalciferol

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:4479094

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:4479094

object_name: secondary hyperparathyroidism


subject: CHEBI:230430

subject_name: Ulinastatin


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: UMLS:C0077906


subject: UMLS:C5239047

subject_name: Anhydrous Enol-oxaloacetate

object_name: glioblastoma


subject: UMLS:C5239047

object_name: Brain Stem Glioblastoma


subject: UMLS:C5239047

object_name: glioma susceptibility 1


subject: CHEBI:30744

subject_name: OXALOACETATE


subject: CHEBI:30744


subject: CHEBI:30744


subject: UMLS:C1521023

subject_name: 2-Amino-9,10-Epoxy-8-Oxodecanoic Acid


subject: UMLS:C1521023


subject: UMLS:C1521023


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Postoperative Complications


subject: CHEBI:64019

subject_name: Nebivolol

object_name: impotence


subject: CHEBI:64019

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:64019

object_name: Erectile dysfunction


subject: CHEBI:229764

subject_name: Selinexor

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Acute respiratory infections


subject: CHEBI:5801

object_name: viral disease


subject: CHEBI:31781

subject_name: Lopinavir


subject: CHEBI:31781


subject: CHEBI:31781

object_name: severe acute respiratory syndrome


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409


subject: CHEBI:45409


subject: CHEBI:80270

object_name: myocardial infarction


subject: CHEBI:80270

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:80270

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:80270

object_name: Reperfusion Injury


subject: PUBCHEM.COMPOUND:52943177

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: PR:000008039


subject: PR:000008039


subject: PR:000008039


subject: PR:000008039


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UMLS:C0061355


subject: UMLS:C0061355


subject: UMLS:C0061355


subject: UMLS:C0061355


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: reported prior thyroid disease (history)


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:8502

subject_name: Propylthiouracil

object_name: Pregnant


subject: CHEBI:8502

object_name: thyroid disease


subject: CHEBI:8502


subject: UMLS:C4727063

subject_name: Ac 225 Monoclonal Antibody J591

object_name: prostate carcinoma


subject: UMLS:C4727063

object_name: prostate cancer


subject: CHEBI:82405

subject_name: Benzoyl peroxide

object_name: herpes simplex


subject: UMLS:C1442791

subject_name: Chocolate antigen

object_name: nutrition related cancer


subject: CHEMBL.COMPOUND:CHEMBL2108921

subject_name: CHOCOLATE


subject: UMLS:C2728194

subject_name: chocolate allergenic extract


subject: DRUGBANK:DB10977

subject_name: Cocoa


subject: UMLS:C0939909

subject_name: Theobroma cacao, cocoa, chocolate


subject: CHEBI:9555

subject_name: Tioguanine

object_name: glioblastoma


subject: CHEBI:9555

object_name: Brain Stem Glioblastoma


subject: CHEBI:9555

object_name: glioma susceptibility 1


subject: CHEBI:9555

object_name: Anaplastic glioma of brain


subject: CHEBI:9555

object_name: brain cancer


subject: CHEBI:9555

object_name: brain neoplasm


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:6520

subject_name: Lomustine


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: UMLS:C2745835

object_name: Heartburn


subject: UMLS:C2745835

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UNII:83U7957287

object_name: liver carcinoma


subject: UNII:83U7957287

object_name: non-small cell lung carcinoma


subject: UMLS:C4085974


subject: UMLS:C4085974


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Antibody-mediated rejection


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:3757

subject_name: Clonidine

object_name: Sedation


subject: CHEBI:3757

object_name: Sedated


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy

object_name: Acute-On-Chronic Liver Failure


subject: PUBCHEM.COMPOUND:72370618

object_name: acute-on-chronic liver failure


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:90926


subject: CHEBI:64312

subject_name: Memantine


subject: CHEBI:64312

object_name: Childhood Glioblastoma


subject: CHEBI:64312

object_name: adult glioblastoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: leukemia


subject: CHEBI:45863

object_name: childhood leukemia


subject: DRUGBANK:DB17626

object_name: hypertriglyceridemia


subject: DRUGBANK:DB17626

object_name: Hypertriglyceridemia, CTCAE


subject: DRUGBANK:DB17626

object_name: hypercholesterolemia, familial, 1


subject: DRUGBANK:DB17626

object_name: familial hypercholesterolemia


subject: DRUGBANK:DB17626

object_name: Dyslipidemia


subject: CHEBI:18085

subject_name: glycosaminoglycan

object_name: HIV infection


subject: UMLS:C3669201

subject_name: GAG (Organic Chemical)


subject: CHEBI:143889

subject_name: galactosaminogalactan


subject: UniProtKB:P10405

subject_name: GAGY_DROME Retrovirus-related Gag polyprotein from transposon gypsy (sprot)


subject: UniProtKB:Q967S7

subject_name: GAGHB_DROME Retrovirus-related Gag polyprotein from transposon HMS-Beagle (sprot)


subject: UniProtKB:P04282

subject_name: GAG17_DROME Retrovirus-related Gag polyprotein from copia-like transposable element 17.6 (sprot)


subject: UniProtKB:P21330

subject_name: GAGJ_DROME Nucleic-acid-binding protein from mobile element jockey (sprot)


subject: UniProtKB:P20828

subject_name: GAG2_DROME Retrovirus-related Gag polyprotein from transposon 297 (sprot)


subject: UniProtKB:Q8I7Q0

subject_name: GAGO_DROME Retrovirus-related Gag polyprotein from transposon opus (sprot)


subject: UMLS:C0019691

subject_name: HIV Envelope Protein gp120


subject: PR:000003229

subject_name: HIV envelope glycoprotein gp120 glycosylated form


subject: PR:000009149

subject_name: inter-alpha-trypsin inhibitor heavy chain H4


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN

object_name: cancer


subject: UNII:E47C0NF7LV

object_name: neoplasm


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: CHEBI:141429

subject_name: Gln-Leu

object_name: Post-Operative Pain


subject: CHEBI:5959

subject_name: Irbesartan

object_name: Severe Sepsis


subject: UMLS:C5205493

subject_name: Pucotenlimab

object_name: Childhood Solid Neoplasm


subject: UMLS:C5205493

object_name: Adult Solid Neoplasm


subject: UMLS:C5205493

object_name: Solid Neoplasm


subject: UMLS:C5205493

object_name: digestive system cancer


subject: CHEBI:50838

subject_name: Drospirenone

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: Hemorrhage


subject: PUBCHEM.COMPOUND:27991

object_name: Postoperative Hemorrhage


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: PUBCHEM.COMPOUND:16051933


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Adenocarcinoma of the prostate stage II


subject: CHEBI:144094

object_name: Adenocarcinoma of the prostate stage I


subject: CHEBI:8772

subject_name: Raloxifene


subject: CHEBI:8772


subject: CHEBI:142708

object_name: Complicated intra-abdominal infection


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: CHEBI:149836

subject_name: Tigecycline


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: Primary hypercholesterolemia


subject: UMLS:C3640130

object_name: Recurrent Gastroesophageal Junction Adenocarcinoma


subject: UMLS:C3640130


subject: UMLS:C3640130

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: UMLS:C3640130

object_name: Adenocarcinoma gastric recurrent


subject: UMLS:C3640130

object_name: Metastatic gastric adenocarcinoma


subject: CHEBI:32087

subject_name: Ramatroban

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:32087

object_name: COVID-19 respiratory infection


subject: CHEBI:232102

object_name: endometriosis


subject: PUBCHEM.COMPOUND:5464076


subject: CHEBI:53329


subject: UNII:DOB7Y3RSX0

subject_name: HPPH

object_name: Squamous cell carcinoma of the oral cavity stage I


subject: UNII:DOB7Y3RSX0

object_name: Squamous cell carcinoma of the oral cavity stage II


subject: CHEBI:6801

subject_name: Metformin

object_name: metastatic prostate carcinoma


subject: UMLS:C5418080

subject_name: FD Inhibitor ALXN2050

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: Occult hepatitis B


subject: CHEBI:59902

object_name: Complication of transplanted liver


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:473990


subject: UMLS:C1170437

subject_name: Normal Saline Flush

object_name: Shock


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: nephrotic syndrome


subject: MESH:D012462

object_name: Nephrotic Syndrome, CTCAE


subject: CHEBI:55340

subject_name: morphine hydrochloride

object_name: Post-Operative Pain


subject: CHEBI:63626

subject_name: Tesamorelin

object_name: Fatty Liver


subject: CHEBI:63626

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:63626

object_name: obesity


subject: CHEBI:63626

object_name: Obesity, CTCAE


subject: CHEBI:63626

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:63626

object_name: Abdominal obesity


subject: UMLS:C1313807


subject: UMLS:C1313807


subject: UMLS:C1313807


subject: UMLS:C1313807


subject: UMLS:C1313807


subject: UMLS:C1313807


subject: CHEBI:8081

subject_name: Phentolamine

object_name: Mydriasis


subject: CHEBI:8081

object_name: Pathological Dilatation


subject: CHEBI:8081

object_name: Dilated


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: Stage II Lung Cancer AJCC v8


subject: UNII:37CQ2C7X93

object_name: Stage I Lung Cancer AJCC v8


subject: UNII:37CQ2C7X93

object_name: Stage IA3 Lung Cancer AJCC v8


subject: UNII:37CQ2C7X93

object_name: Stage IA2 Lung Cancer AJCC v8


subject: UNII:37CQ2C7X93

object_name: Stage IA1 Lung Cancer AJCC v8


subject: UNII:37CQ2C7X93

object_name: Stage IB Lung Cancer AJCC v8


subject: UNII:37CQ2C7X93

object_name: Stage III Lung Cancer AJCC v8


subject: UNII:37CQ2C7X93

object_name: Stage IIB Lung Cancer AJCC v8


subject: UNII:37CQ2C7X93

object_name: Stage IIA Lung Cancer AJCC v8


subject: UNII:37CQ2C7X93

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UNII:37CQ2C7X93

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UNII:37CQ2C7X93

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UNII:37CQ2C7X93

object_name: lung carcinoma


subject: UMLS:C2718754

subject_name: Ilaris


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: PUBCHEM.COMPOUND:637

subject_name: Cytosine deoxyribonucleoside

object_name: telomere syndrome


subject: PUBCHEM.COMPOUND:637

object_name: Hoyeraal-Hreidarsson syndrome


subject: PUBCHEM.COMPOUND:637

object_name: X-Linked Dyskeratosis Congenita


subject: PUBCHEM.COMPOUND:637

object_name: dyskeratosis congenita, X-linked


subject: PUBCHEM.COMPOUND:637

object_name: dyskeratosis congenita


subject: PUBCHEM.COMPOUND:637

object_name: Revesz Syndrome


subject: CHEBI:15698

subject_name: Deoxycytidine


subject: CHEBI:15698


subject: CHEBI:15698


subject: CHEBI:15698


subject: CHEBI:15698


subject: CHEBI:15698


subject: UMLS:C0086126


subject: UMLS:C0086126


subject: UMLS:C0086126


subject: UMLS:C0086126


subject: UMLS:C0086126


subject: UMLS:C0086126


subject: CHEBI:17748

subject_name: Thymidine


subject: CHEBI:17748


subject: CHEBI:17748


subject: CHEBI:17748


subject: CHEBI:17748


subject: CHEBI:17748


subject: CHEBI:71013

subject_name: Perampanel

object_name: amyotrophic lateral sclerosis


subject: UMLS:C4287757

subject_name: Anti-GITR Monoclonal Antibody GWN 323

object_name: lymphoma


subject: UMLS:C4287757

object_name: Solid Neoplasm


subject: UMLS:C4053607


subject: MESH:D022242

subject_name: Pneumococcal Vaccines

object_name: pneumococcal infection


subject: MESH:D022242

object_name: herpes zoster


subject: UMLS:C5240157

subject_name: Vaccine product containing only Streptococcus pneumoniae antigen (medicinal product)


subject: UMLS:C5240157


subject: UNII:AHI9T7EDX6

subject_name: Pneumovax 23


subject: RXCUI:287523


subject: CHEBI:33380

subject_name: thulium atom

object_name: nicotine dependence


subject: CHEBI:33380

object_name: Tabagism


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:74861


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:55460


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: UMLS:C3166394

subject_name: Tm antigen


subject: UMLS:C3166394


subject: PR:000002105

subject_name: thrombomodulin


subject: PR:000002105


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: Primary malignant neoplasm


subject: PUBCHEM.COMPOUND:5466794

object_name: cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: childhood malignant neoplasm


subject: PUBCHEM.COMPOUND:5466794

object_name: Malignant obstetric neoplasm


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: UMLS:C4305920

object_name: hepatitis C


subject: UMLS:C4305920

object_name: chronic hepatitis C virus infection


subject: UMLS:C4278474

object_name: inflammatory bowel disease


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL

object_name: Disorder of urinary stent


subject: CHEBI:144551

subject_name: Oxybutynin


subject: CHEBI:9398

subject_name: Tamsulosin


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: Food-Drug Interactions


subject: CHEBI:229221

object_name: Drug Interactions


subject: CHEBI:229221

object_name: Adverse drug interaction


subject: UMLS:C3540798

subject_name: Food allergenic extracts


subject: UMLS:C3540798


subject: UMLS:C3540798


subject: CHEBI:8768

subject_name: Rabeprazole


subject: CHEBI:8768


subject: CHEBI:8768


subject: CHEBI:6832

subject_name: Methocarbamol

object_name: Ureter Disorder


subject: CHEBI:6832

object_name: kidney disorder


subject: CHEBI:6832

object_name: Ureteral Calculi


subject: CHEBI:6832

object_name: ureterolithiasis


subject: CHEBI:6832

object_name: nephrolithiasis


subject: CHEBI:6832

object_name: Kidney Calculi


subject: CHEBI:6832

object_name: urolithiasis


subject: PUBCHEM.COMPOUND:86217377


subject: PUBCHEM.COMPOUND:86217377


subject: PUBCHEM.COMPOUND:86217377


subject: PUBCHEM.COMPOUND:86217377


subject: PUBCHEM.COMPOUND:86217377


subject: PUBCHEM.COMPOUND:86217377


subject: PUBCHEM.COMPOUND:86217377


subject: CHEBI:144551


subject: CHEBI:144551


subject: CHEBI:144551


subject: CHEBI:144551


subject: CHEBI:144551


subject: CHEBI:144551


subject: CHEBI:144551


subject: CHEMBL.COMPOUND:CHEMBL4594594

subject_name: ITEPEKIMAB

object_name: bronchiectasis


subject: UMLS:C5421034

subject_name: itepekimab


subject: UMLS:C5565157


subject: CHEBI:16899

subject_name: Mannitol

object_name: opiate dependence


subject: UNII:7R7G6EH5UL

subject_name: Navtemadlin

object_name: Refractory acute myeloid leukemia


subject: UNII:7R7G6EH5UL

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:7R7G6EH5UL

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:132774

subject_name: Roxadustat

object_name: ST-elevation myocardial infarction


subject: CHEBI:132774

object_name: ST Elevation Myocardial Infarction


subject: UMLS:C3713379


subject: UMLS:C3713379


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:181069

object_name: HIV infection


subject: PUBCHEM.COMPOUND:14021140


subject: CHEBI:10101

subject_name: Zalcitabine


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: decubitus ulcer


subject: CHEBI:16796

subject_name: Melatonin


subject: UNII:0NIZ8H6OL8

subject_name: Tetrahydrouridine

object_name: head and neck neoplasm


subject: UNII:0NIZ8H6OL8

object_name: bladder tumor


subject: UNII:0NIZ8H6OL8

object_name: breast neoplasm


subject: UNII:0NIZ8H6OL8

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: PUBCHEM.COMPOUND:435949


subject: PUBCHEM.COMPOUND:435949


subject: PUBCHEM.COMPOUND:435949


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:74327


subject: UMLS:C3826849

subject_name: Fluorine F 18 5-Fluoro-2-deoxycytidine


subject: UMLS:C3826849


subject: UMLS:C3826849


subject: UMLS:C3826849


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Overweight


subject: CHEBI:40279

object_name: Blood Pressure Finding


subject: CHEBI:40279

object_name: Systemic arterial pressure


subject: CHEBI:40279

object_name: Renal Function


subject: CHEBI:40279

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:40279

object_name: obesity


subject: CHEBI:40279

object_name: Obesity, CTCAE


subject: CHEBI:8426

subject_name: Probenecid


subject: CHEBI:8426


subject: CHEBI:8426


subject: CHEBI:8426


subject: CHEBI:8426


subject: CHEBI:8426


subject: CHEBI:8426


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Malignant pleural effusion


subject: UNII:6XC1PAD3KF

object_name: non-small cell lung carcinoma


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: UMLS:C1815180

subject_name: Kogenate FS

object_name: hemophilia A


subject: CHEBI:145499

subject_name: Donepezil

object_name: mild neurocognitive disorder


subject: CHEBI:145499

object_name: mild cognitive impairment


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage II Lung Cancer AJCC v6


subject: CHEBI:31355

object_name: Stage II Lung Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage II Lung Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage I Lung Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage I Lung Cancer AJCC v6


subject: CHEBI:31355

object_name: Stage I Lung Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage III Lung Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage III Lung Cancer


subject: CHEBI:31355

object_name: Stage III Lung Cancer AJCC v6


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Small cell lung cancer limited stage


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:L585GDK9YN

subject_name: BIFIDOBACTERIUM BREVE BR03

object_name: Pediatric Obesity


subject: UNII:9N4P294L2R

subject_name: BIFIDOBACTERIUM BREVE B632


subject: CHEBI:499361

subject_name: Aprepitant

object_name: cannabis abuse


subject: CHEBI:499361

object_name: alcohol abuse


subject: CHEBI:499361

object_name: alcohol dependence


subject: CHEBI:499361

object_name: Cannabis use disorder


subject: PUBCHEM.COMPOUND:6331784

subject_name: Sodium risedronate

object_name: osteoporosis


subject: PUBCHEM.COMPOUND:6331784

object_name: Encounter due to family history of osteoporosis


subject: PUBCHEM.COMPOUND:6331784

object_name: Osteoporosis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:6331784

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: ulcerative colitis


subject: CHEBI:29007

object_name: inflammatory bowel disease 1


subject: CHEBI:29007

object_name: inflammatory bowel disease


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Alveolalgia


subject: UMLS:C4725072

subject_name: Astragalus membranaceus/Angelica gigas/Trichosanthes kirilowii Maximowicz Mixed Herbal Extract SH003

object_name: Adult Solid Neoplasm


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: acute coronary syndrome


subject: CHEBI:7986

subject_name: Pentoxifylline


subject: UMLS:C2346819

subject_name: tanezumab

object_name: postherpetic neuralgia


subject: CHEBI:231679

subject_name: ipilimumab

object_name: glioblastoma


subject: CHEBI:231679

object_name: Childhood Glioblastoma


subject: CHEBI:231679

object_name: adult glioblastoma


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine

object_name: cancer


subject: UNII:884KT10YB7

object_name: neoplasm


subject: CHEBI:8776

subject_name: ranitidine


subject: CHEBI:8776


subject: MESH:D003287

subject_name: Contrast Media

object_name: myocardial infarction


subject: MESH:D003287

object_name: Myocardial Infarction, CTCAE


subject: MESH:D003287

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:33375

subject_name: Gadolinium


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: UNII:T432289GYZ

subject_name: Sinecatechins

object_name: Childhood Breast Carcinoma


subject: UNII:T432289GYZ

object_name: breast carcinoma


subject: UNII:T432289GYZ

object_name: breast cancer


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: trigeminal neuralgia


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:3387

subject_name: Carbamazepine


subject: CHEBI:16867

subject_name: D-Methionine

object_name: noise induced hearing loss


subject: CHEBI:16867

object_name: acoustic trauma (history)


subject: UMLS:C4534672


subject: UMLS:C4534672


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: lip and oral cavity carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: lung cancer


subject: MESH:D000077203

object_name: lung neoplasm


subject: MESH:D000077203

object_name: lung carcinoma


subject: CHEBI:31401

subject_name: Cilostazol

object_name: arteriosclerosis obliterans


subject: CHEBI:8427

subject_name: Probucol


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: castration-resistant prostate carcinoma


subject: CHEBI:231005

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:231005

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:231005

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:231005

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:231005

object_name: Prostate cancer recurrent


subject: CHEBI:231005

object_name: prostate adenocarcinoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: common cold


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:59163

subject_name: biomarker

object_name: Alzheimer disease


subject: CHEBI:59163

object_name: mild neurocognitive disorder


subject: CHEBI:59163

object_name: mild cognitive impairment


subject: CHEBI:191852

subject_name: Ergmt


subject: CHEBI:191852


subject: CHEBI:191852


subject: UMLS:C0009392

subject_name: Colony-Stimulating Factors


subject: UMLS:C0009392


subject: UMLS:C0009392


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376561

subject_name: Recombinant Colony-Stimulating Factors


subject: UMLS:C0376561


subject: UMLS:C0376561


subject: CHEBI:9720

subject_name: Trihexyphenidyl

object_name: dystonia


subject: CHEBI:31174

subject_name: Adapalene

object_name: Solar elastosis


subject: GTOPDB:7785

subject_name: mavrilimumab

object_name: temporal arteritis


subject: UNII:1158JD1P9A


subject: UMLS:C2987425


subject: CHEBI:52172

subject_name: Nilotinib

object_name: Huntington disease


subject: CHEBI:230016

object_name: neoplasm


subject: UNII:0NIZ8H6OL8

subject_name: Tetrahydrouridine


subject: CHEBI:36946

subject_name: thiourea


subject: UMLS:C1327897

subject_name: Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine

object_name: adult lymphoma


subject: UMLS:C1327897

object_name: lymphoma


subject: UMLS:C1327897

object_name: pediatric lymphoma


subject: UMLS:C1327897

object_name: small intestine cancer


subject: UMLS:C1327897

object_name: small intestine carcinoma


subject: UMLS:C1327897

object_name: lymphoproliferative syndrome


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:75551

object_name: diabetic macular edema


subject: CHEBI:124959

subject_name: Tilarginine


subject: CHEBI:124959

object_name: Upper Respiratory Infections


subject: CHEBI:124959

object_name: chronic obstructive pulmonary disease


subject: CHEBI:124959

object_name: hyperemia


subject: CHEBI:124959

object_name: Raynaud disease


subject: UMLS:C0069477

object_name: common cold


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: congenital heart disease


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine

object_name: High Risk Myelodysplastic Syndrome


subject: CHEBI:74705

subject_name: Met-Leu

object_name: phlebitis


subject: CHEBI:74705

object_name: Phlebitis, CTCAE


subject: CHEBI:74705

object_name: Infection of intravenous catheter


subject: CHEBI:74705

object_name: Extravasation of Diagnostic and Therapeutic Materials


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:6121

subject_name: Ketamine

object_name: Phantom pain


subject: CHEBI:6121

object_name: Phantom Limb


subject: CHEBI:6121

object_name: Phantom Limb Pain


subject: CHEBI:6121

object_name: Phantom Pain, CTCAE 5.0


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid


subject: PUBCHEM.COMPOUND:4715169


subject: PUBCHEM.COMPOUND:4715169


subject: PUBCHEM.COMPOUND:4715169


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:64356


subject: UMLS:C4683552

object_name: cancer


subject: UMLS:C4683552

object_name: neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: lichen planus, oral


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Parkinson disease


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin


subject: CHEBI:63660

object_name: type 2 diabetes mellitus


subject: CHEBI:63660

object_name: hypertension


subject: CHEBI:63660

object_name: Hypertension, CTCAE


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:4672

subject_name: Docetaxel

object_name: endometrial cancer


subject: CHEBI:4672

object_name: uterine corpus cancer


subject: CHEBI:188219

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:188219


subject: UNII:2GFP9BJD79

subject_name: Glucarpidase

object_name: diffuse large B-cell lymphoma


subject: UNII:2GFP9BJD79

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:2GFP9BJD79

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:2GFP9BJD79

object_name: Drug toxicity


subject: UNII:8WL68J66B9

subject_name: HEPALATIDE

object_name: chronic hepatitis B virus infection


subject: UNII:8WL68J66B9

object_name: hepatitis B


subject: CHEMBL.COMPOUND:CHEMBL4594569

subject_name: AMLITELIMAB

object_name: hidradenitis


subject: UMLS:C5555444

subject_name: Amlitelimab


subject: CHEBI:47426

subject_name: Furosemide

object_name: nephrolithiasis


subject: CHEBI:47426

object_name: urolithiasis


subject: CHEBI:47426

object_name: ureterolithiasis


subject: CHEBI:47426

object_name: Urinary Calculi


subject: CHEBI:135515

subject_name: Bendamustine

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:135515

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:135515

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:135515

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:135515

object_name: lymphoid neoplasm


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UMLS:C3892863

subject_name: filgrastim-sndz

object_name: adult lymphoma


subject: UMLS:C3892863

object_name: lymphoma


subject: UMLS:C3892863

object_name: pediatric lymphoma


subject: UMLS:C3892863

object_name: acute lymphoblastic leukemia


subject: UMLS:C3892863


subject: UMLS:C3892863


subject: UMLS:C3892863


subject: UMLS:C3892863


subject: UMLS:C3892863


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: UMLS:C1176021

object_name: metastatic melanoma


subject: CHEBI:91541

object_name: Labor Pain


subject: CHEBI:8461

subject_name: Promethazine


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Intravenous Drug Usage


subject: UMLS:C1879535

subject_name: Acetyl-L-carnitine hydrochloride

object_name: Childhood Breast Carcinoma


subject: UMLS:C1879535

object_name: breast carcinoma


subject: UMLS:C1879535

object_name: breast cancer


subject: UMLS:C1879535

object_name: neuropathy


subject: UMLS:C1879535

object_name: Chemotherapeutic Agent Toxicity


subject: UMLS:C1879535

object_name: neurotoxicity


subject: UMLS:C1879535

object_name: Fatigue, CTCAE 5.0


subject: UMLS:C1879535

object_name: Fatigue


subject: CHEBI:84500

subject_name: varenicline

object_name: opiate dependence


subject: CHEBI:84500

object_name: chronic pain (diagnosis)


subject: CHEBI:84500

object_name: Chronic pain


subject: UMLS:C5554963

subject_name: Multi-kinase Inhbitor AIV001

object_name: keloid


subject: UMLS:C5554963

object_name: Cicatrization


subject: UMLS:C5554963

object_name: Surgical wound


subject: CHEBI:125400

subject_name: actinomycin D

object_name: leukemia


subject: CHEBI:125400

object_name: childhood leukemia


subject: CHEBI:125400

object_name: adult lymphoma


subject: CHEBI:125400

object_name: lymphoma


subject: CHEBI:125400

object_name: pediatric lymphoma


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:132967

subject_name: Elbasvir

object_name: Cryoglobulinemic glomerulonephritis


subject: UNII:4O2AB118LA

subject_name: GRAZOPREVIR


subject: CHEBI:132975

subject_name: Grazoprevir


subject: CHEBI:233309

subject_name: Adagrasib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:195559

subject_name: Poziotinib

object_name: Carcinoma breast stage IV


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Inflammatory carcinoma of breast stage III


subject: UNII:28X28X9OKV

object_name: invasive breast carcinoma


subject: UNII:28X28X9OKV

object_name: HER2 positive breast carcinoma


subject: UNII:28X28X9OKV

object_name: HER2-Low Breast Carcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UNII:UVJ7NL8S2P

subject_name: Imlifidase

object_name: Kidney transplant failure and rejection


subject: CHEBI:49960

subject_name: Vandetanib

object_name: Childhood Breast Carcinoma


subject: CHEBI:49960

object_name: breast carcinoma


subject: CHEBI:49960

object_name: breast cancer


subject: GTOPDB:8088

subject_name: epratuzumab

object_name: B-cell acute lymphoblastic leukemia


subject: CHEMBL.COMPOUND:CHEMBL2108404

subject_name: EPRATUZUMAB


subject: UMLS:C0281743


subject: UMLS:C4722548

subject_name: GSK2110183 IR Tablet

object_name: cancer


subject: UMLS:C4722548

object_name: neoplasm


subject: UNII:17Y5QL6ENT

subject_name: DOCIPARSTAT

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C5417776

subject_name: CYP17/CYP11B2 Inhibitor LAE001

object_name: metastatic prostate carcinoma


subject: CHEBI:231356

subject_name: Varlitinib


subject: UMLS:C4732973


subject: CHEBI:231683

subject_name: Anakinra

object_name: asthma


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: UMLS:C1135618

subject_name: Dermatophagoides farinae antigen


subject: DRUGBANK:DB10400

subject_name: Dermatophagoides farinae


subject: UNII:2372V1TKXK

subject_name: Lanadelumab

object_name: angioedema


subject: UMLS:C4044724


subject: UNII:XW8D2TV27D

subject_name: Amg 579

object_name: schizophrenia


subject: UMLS:C4045945

subject_name: AMG 579


subject: CHEBI:10112

subject_name: Zileuton

object_name: lung cancer


subject: CHEBI:10112

object_name: lung neoplasm


subject: CHEBI:10112

object_name: lung carcinoma


subject: CHEBI:10112

object_name: Neck Carcinoma


subject: CHEBI:10112

object_name: head and neck neoplasm


subject: CHEBI:10112

object_name: head and neck cancer


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:92043599

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:92043599

object_name: breast cancer


subject: CHEBI:229233

subject_name: Ritlecitinib

object_name: Pseudopelade


subject: CHEBI:229233

object_name: Scarring alopecia of scalp


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: lung adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: cervical adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: bile duct adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: Tumor Mass


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994

object_name: gastric adenocarcinoma


subject: CHEBI:85994


subject: CHEBI:187893

subject_name: Baclofen

object_name: Crying, excessive


subject: CHEBI:49575

subject_name: Diazepam

object_name: cerebral palsy


subject: CHEBI:49575


subject: CHEBI:3756

subject_name: Clonazepam


subject: CHEBI:3756


subject: CHEBI:9720

subject_name: Trihexyphenidyl


subject: CHEBI:9720


subject: CHEBI:64030

subject_name: tetrabenazine


subject: CHEBI:64030


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:42797


subject: CHEBI:63631

subject_name: Topiramate


subject: CHEBI:63631


subject: CHEBI:6367

subject_name: Lamotrigine


subject: CHEBI:6367


subject: CHEBI:145500

subject_name: thiencarbazone-methyl

object_name: kidney disorder


subject: CHEBI:145500

object_name: proteinuria


subject: CHEBI:145500

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:145500

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:145500

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:145500

object_name: Hereditary nephropathy


subject: CHEBI:35255

subject_name: Chloroform


subject: CHEBI:35255


subject: CHEBI:35255


subject: CHEBI:35255


subject: CHEBI:35255


subject: CHEBI:35255


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: FLT3 gene mutation


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:145372

subject_name: Gilteritinib


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Adverse drug response


subject: CHEBI:71219

object_name: Self efficacy (finding)


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: squamous cell lung carcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:DEH7Q6472O

subject_name: Ladarixin

object_name: type 1 diabetes mellitus


subject: UNII:X8BW0MQ5PI

object_name: myelofibrosis


subject: GTOPDB:13876

subject_name: nipocalimab

object_name: lupus nephritis


subject: UNII:87M90CV8NC

subject_name: NIPOCALIMAB


subject: UMLS:C5417823


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: non-small cell lung carcinoma


subject: CHEBI:173077


subject: CHEBI:4953

subject_name: Exemestane

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:36796

subject_name: duloxetine

object_name: Postoperative Pain, Acute


subject: CHEBI:36796

object_name: opioid use


subject: CHEBI:36796

object_name: Postoperative Pain, Chronic


subject: CHEBI:36796

object_name: opiate dependence


subject: GTOPDB:12989

subject_name: toripalimab

object_name: gastric adenocarcinoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4547969

subject_name: apatinib mesylate


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: cocaine abuse


subject: CHEBI:74327

subject_name: Ile-Val


subject: UNII:9R3D3Y0UHS

subject_name: Elapegademase

object_name: severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency


subject: UMLS:C4731736

subject_name: elapegademase


subject: UNII:C1KR8TZ3NE

subject_name: EFRUXIFERMIN


subject: UMLS:C5446735

subject_name: Efruxifermin


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: autoimmune inner ear disease


subject: CHEBI:16796

subject_name: Melatonin

object_name: Catheter related infection


subject: CHEBI:141474

subject_name: Malathion


subject: UMLS:C3847816

subject_name: Vitamin K Antagonist - Drug

object_name: hemophilia A


subject: UMLS:C3847816

object_name: hemophilia B


subject: UMLS:C3847816

object_name: hemophilia B leyden


subject: UMLS:C3847816

object_name: Anticoagulant-induced bleeding


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: liver cancer


subject: CHEBI:63791

object_name: liver neoplasm


subject: CHEBI:63791

object_name: Adult Liver Carcinoma


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IV Bladder Cancer AJCC v7


subject: CHEBI:4672

object_name: Bladder cancer stage IV


subject: CHEBI:4672

object_name: Stage IV Bladder Cancer AJCC v6


subject: CHEBI:4672

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: CHEBI:4672

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:49603

subject_name: Lapatinib


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603

object_name: transitional cell carcinoma


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603

object_name: Bladder cancer recurrent


subject: CHEBI:600103

subject_name: daptomycin

object_name: Febrile Neutropenia


subject: CHEBI:600103

object_name: Febrile Neutropenia, CTCAE


subject: CHEBI:87681

subject_name: Ranolazine

object_name: Diarrhea predominant irritable bowel syndrome


subject: CHEMBL.COMPOUND:CHEMBL2109477

subject_name: SELICRELUMAB

object_name: Solid Neoplasm


subject: UMLS:C1869412


subject: UMLS:C2348031

subject_name: Cysteine-Rich Non-Denatured Whey Protein Isolate IMN1207

object_name: non-small cell lung carcinoma


subject: CHEBI:9907

subject_name: ursodiol

object_name: gastric intestinal metaplasia


subject: UMLS:C4086527

subject_name: Iodine I 131 Tenatumomab

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4086527

object_name: non-Hodgkin lymphoma


subject: UMLS:C4086527

object_name: breast neoplasm


subject: UMLS:C4086527

object_name: connective and soft tissue neoplasm


subject: UMLS:C4086527

object_name: sarcoma


subject: UMLS:C4086527

object_name: head and neck neoplasm


subject: UMLS:C4086527

object_name: head and neck cancer


subject: UMLS:C4086527

object_name: digestive system neoplasm


subject: UMLS:C4086527

object_name: Neoplasm of the gastrointestinal tract


subject: UMLS:C4086527

object_name: respiratory tract neoplasm


subject: UMLS:C4086527

object_name: pancreatic neoplasm


subject: UMLS:C4086527

object_name: malignant pancreatic neoplasm


subject: UMLS:C4086527

object_name: Neoplasm of the genitourinary tract


subject: UMLS:C4086527

object_name: skin neoplasm


subject: UMLS:C3896910


subject: UMLS:C3827085

object_name: Carcinoma breast stage IV


subject: GTOPDB:8267

subject_name: milatuzumab

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: GTOPDB:8267

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: GTOPDB:8267

object_name: Myelodysplasia


subject: GTOPDB:8267

object_name: Adult Myelodysplastic Syndrome


subject: GTOPDB:8267

object_name: childhood myelodysplastic syndrome


subject: GTOPDB:8267

object_name: Myelodysplastic Syndrome, CTCAE


subject: GTOPDB:8267

object_name: plasma cell myeloma


subject: UNII:2OP4E0GC6V


subject: UNII:2OP4E0GC6V


subject: UNII:2OP4E0GC6V


subject: UNII:2OP4E0GC6V


subject: UNII:2OP4E0GC6V


subject: UNII:2OP4E0GC6V


subject: UNII:2OP4E0GC6V


subject: UMLS:C2716103


subject: UMLS:C2716103


subject: UMLS:C2716103


subject: UMLS:C2716103


subject: UMLS:C2716103


subject: UMLS:C2716103


subject: UMLS:C2716103


subject: CHEBI:35441

subject_name: antiinfective agent

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:52717

subject_name: Bortezomib


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag


subject: CHEBI:45783

subject_name: Imatinib


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: liver cancer


subject: CHEBI:45783

object_name: Eosinophilic disorder


subject: CHEBI:45783

object_name: Eosinophilia


subject: CHEBI:45783

object_name: Eosinophilia, CTCAE


subject: CHEBI:23359

subject_name: colchicine

object_name: Decompensated cardiac failure


subject: CHEBI:23359

object_name: Heart failure with reduced ejection fraction


subject: PUBCHEM.COMPOUND:73945175

subject_name: Implitapide

object_name: hypercholesterolemia, familial, 1


subject: PUBCHEM.COMPOUND:73945175

object_name: familial hypercholesterolemia


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Cannabis use disorder


subject: CHEBI:16646

subject_name: carbohydrate

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:16646

object_name: Fatigue


subject: CHEBI:16646

object_name: Exercise induced muscle damage


subject: CHEBI:18167

subject_name: alpha-maltose


subject: CHEBI:18167


subject: CHEBI:18167


subject: CHEMBL.COMPOUND:CHEMBL2107951

subject_name: MALTODEXTRIN


subject: CHEMBL.COMPOUND:CHEMBL2107951


subject: CHEMBL.COMPOUND:CHEMBL2107951


subject: UMLS:C5964773

subject_name: Toll-like Receptor 7/8 Agonist EIK1001

object_name: Advanced Melanoma


subject: CHEBI:125427


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: UMLS:C1440867

subject_name: lactoferrin, bovine

object_name: Neonatal disorder


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: postmenopausal osteoporosis


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:3757

subject_name: Clonidine

object_name: pregnancy related


subject: PUBCHEM.COMPOUND:62690

subject_name: carbogen

object_name: Febrile Seizure


subject: CHEMBL.COMPOUND:CHEMBL4297716

subject_name: CARBOGEN


subject: CHEBI:231693

subject_name: Capmatinib

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:231693

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:231693

object_name: Stage IV Lung Cancer AJCC v7


subject: CHEBI:231693

object_name: Stage IV Lung Cancer AJCC v6


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: PUBCHEM.COMPOUND:142464264

object_name: iron deficiency anemia


subject: DRUGBANK:DB19111


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Advanced Squamous Cell Carcinoma


subject: UMLS:C4053601


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: squamous cell carcinoma


subject: UNII:Q46947FE7K

object_name: skin squamous cell carcinoma


subject: UNII:Q46947FE7K

object_name: cutaneous squamous cell carcinoma


subject: UNII:Q46947FE7K


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: Interstitial pneumonitis


subject: CHEBI:135765

subject_name: Methylprednisolone hemisuccinate

object_name: acute respiratory distress syndrome


subject: CHEBI:135765

object_name: adult acute respiratory distress syndrome


subject: CHEBI:135765

object_name: Postoperative Complications


subject: CHEBI:135765

object_name: acute lung injury


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: UMLS:C5772817

subject_name: VBI-2901a COVID-19 vaccine


subject: UMLS:C5772817

object_name: Coronavinae infectious disease


subject: UMLS:C3714737

subject_name: Phytonadione Drug Class

object_name: complication


subject: UMLS:C3714737

object_name: Hemorrhage


subject: CHEBI:18067

subject_name: Phylloquinone


subject: CHEBI:18067


subject: RXCUI:236782

subject_name: Saccharomyces boulardii Oral Capsule

object_name: irritable bowel syndrome


subject: CHEBI:94531

subject_name: belinostat

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:94531

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:94531

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:94531

object_name: non-Hodgkin lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297777

object_name: pancreatic adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297777

object_name: Extrahepatic Cholangiocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297777

object_name: malignant epithelioid mesothelioma


subject: UMLS:C4044528


subject: UMLS:C4044528


subject: UMLS:C4044528


subject: CHEBI:71200

subject_name: Tofacitinib


subject: CHEBI:71200


subject: CHEBI:71200


subject: UNII:981TME683S

subject_name: Ropeginterferon alfa-2b

object_name: acquired polycythemia vera


subject: UMLS:C3827091


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Stomach cancer


subject: CHEBI:95021

object_name: gastric cancer


subject: CHEBI:63724


subject: CHEBI:63724


subject: PR:000004036

subject_name: progressive ankylosis protein

object_name: Stage IV Cutaneous Merkel Cell Carcinoma AJCC v7


subject: PR:000004036

object_name: stage IV Merkel cell carcinoma


subject: PR:000004036

object_name: Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8


subject: PR:000004033


subject: PR:000004033


subject: PR:000004033


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: CHEBI:188197

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:188197

object_name: clear cell renal carcinoma


subject: CHEBI:188197

object_name: renal cell adenocarcinoma


subject: CHEBI:188197

object_name: renal cell carcinoma


subject: CHEBI:188197

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:188197

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:188197

object_name: sarcoma


subject: CHEBI:188197

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:188197

object_name: soft tissue sarcoma


subject: CHEBI:188197

object_name: metastatic neoplasm


subject: CHEBI:188197

object_name: Embolism, Tumor


subject: CHEBI:188197

object_name: Neoplasm Metastasis


subject: CHEBI:188197

object_name: Metastatic Lesion


subject: CHEBI:71219

subject_name: Pazopanib


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: UNII:660M185X4D

object_name: hyperglycemia


subject: CHEBI:6801

subject_name: Metformin

object_name: Cytopenia


subject: CHEBI:6801

object_name: Myelodysplasia


subject: CHEBI:6801

object_name: preleukemic anemia


subject: CHEBI:31905

subject_name: Nicorandil

object_name: type 2 diabetes mellitus


subject: CHEBI:31905

object_name: Insulin resistance


subject: CHEBI:143658

object_name: plasma cell myeloma


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:125628

subject_name: Alisertib

object_name: leiomyosarcoma of the corpus uteri


subject: CHEBI:125628

object_name: Recurrent Uterine Corpus Sarcoma


subject: CHEBI:15383

object_name: thrombocytopenia 1


subject: CHEBI:15384

subject_name: limonene


subject: MESH:C000710607

object_name: eosinophilic esophagitis


subject: MESH:C000710607

object_name: Eosinophilic infiltration of the esophagus


subject: UMLS:C5417896

subject_name: DNA-PK/PI3K-delta Inhibitor BR101801

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5417896

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C5417896

object_name: B-cell neoplasm


subject: UMLS:C5417896

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5417896

object_name: follicular lymphoma


subject: UMLS:C5417896

object_name: marginal zone lymphoma


subject: UMLS:C5417896

object_name: MALT lymphoma


subject: UMLS:C5417896

object_name: Waldenstrom macroglobulinemia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: eosinophilic granulomatosis with polyangiitis


subject: UMLS:C0295415

subject_name: rituximab


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:78140854

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:78140854

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:78140854

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:78140854

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Marinesco-Sjogren syndrome


subject: PUBCHEM.COMPOUND:78140854

object_name: Microsatellite Stable


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: PUBCHEM.COMPOUND:11714998

subject_name: ABT 510

object_name: brain neoplasm


subject: UMLS:C1569206


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:73151030

object_name: Pulmonary Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:73151030

object_name: Right Ventricular Dysfunction


subject: PUBCHEM.COMPOUND:73151030

object_name: Right Ventricular Dysfunction, CTCAE


subject: PUBCHEM.COMPOUND:73151030

object_name: Right ventricular failure


subject: CHEBI:87681

subject_name: Ranolazine


subject: CHEBI:87681


subject: CHEBI:87681


subject: CHEBI:87681


subject: PUBCHEM.COMPOUND:28125489

subject_name: Focalin XR

object_name: attention deficit hyperactivity disorder, inattentive type


subject: PUBCHEM.COMPOUND:28125489


subject: UMLS:C1659527


subject: UMLS:C1659527


subject: CHEBI:51860

subject_name: Dexmethylphenidate


subject: CHEBI:51860


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: adult lymphoma


subject: UMLS:C0013227

object_name: lymphoma


subject: UMLS:C0013227

object_name: pediatric lymphoma


subject: UMLS:C0013227

object_name: acute lymphoblastic leukemia


subject: UMLS:C0013227

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:XAV9KYN9WL

object_name: myelofibrosis


subject: UNII:XAV9KYN9WL

object_name: Myelodysplasia


subject: UNII:XAV9KYN9WL

object_name: acute myeloid leukemia by FAB classification


subject: UNII:XAV9KYN9WL

object_name: acute myeloid leukemia


subject: UNII:XAV9KYN9WL

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:XAV9KYN9WL


subject: UNII:234248D0HH

subject_name: Tucatinib

object_name: Childhood Breast Carcinoma


subject: UNII:234248D0HH

object_name: breast carcinoma


subject: UNII:234248D0HH

object_name: breast cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Mucosal Melanoma of the Head and Neck


subject: CHEBI:4031

subject_name: Cyclosporine

object_name: alopecia areata


subject: CHEBI:4031

object_name: alopecia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:4026

object_name: myoclonic dystonia 11


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: GTOPDB:4934

subject_name: G-CSF


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:62932

subject_name: mycophenolate


subject: CHEBI:62932


subject: CHEBI:62932


subject: CHEBI:62932


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:64310

subject_name: Crizotinib

object_name: Stomach cancer


subject: CHEBI:64310

object_name: gastric cancer


subject: CHEBI:64310

object_name: triple-negative breast carcinoma


subject: CHEBI:64310

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:64310

object_name: breast lobular carcinoma


subject: CHEBI:64310

object_name: CDH1 Gene Mutation


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Malignant neoplasm of pancreas resectable


subject: UMLS:C4054250

object_name: squamous cell carcinoma


subject: UMLS:C4054250

object_name: head and neck squamous cell carcinoma


subject: UNII:6734037O3L

subject_name: Tesaglitazar

object_name: type 2 diabetes mellitus


subject: CHEBI:32195


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: bladder tumor


subject: CHEBI:41774

object_name: urinary bladder carcinoma


subject: CHEBI:41774

object_name: urinary bladder cancer


subject: CHEBI:41774

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:11963629

subject_name: ferryl iron

object_name: chronic kidney disease


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: pain agnosia


subject: CHEBI:3215

object_name: Pain insensitivity


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate


subject: CHEBI:2636

subject_name: Amifostine


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C0169964

subject_name: somatropin


subject: MESH:D004573

subject_name: Electrolytes

object_name: Constipation


subject: MESH:D004573

object_name: Constipation, CTCAE


subject: UMLS:C3536863

subject_name: Electrolyte [EPC]


subject: UMLS:C3536863


subject: MESH:C530960

subject_name: yunnan baiyao

object_name: diabetic foot


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: atrial fibrillation


subject: CHEBI:38545

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:38545

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:38545

object_name: Myocardial injury


subject: GTOPDB:9109

object_name: Childhood Solid Neoplasm


subject: GTOPDB:9109

object_name: Adult Solid Neoplasm


subject: GTOPDB:9109

object_name: Solid Neoplasm


subject: UMLS:C3273043


subject: UMLS:C3273043


subject: UMLS:C3273043


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UNII:XNM7LT65NP

object_name: Pseudomonas aeruginosa infection


subject: UNII:XNM7LT65NP

object_name: cystic fibrosis


subject: UMLS:C2698293

subject_name: Aztreonam lysine


subject: UMLS:C2698293


subject: CHEBI:90942

subject_name: Ixazomib

object_name: malignant soft tissue neoplasm


subject: CHEBI:90942

object_name: sarcoma


subject: CHEBI:90942

object_name: alveolar soft part sarcoma


subject: CHEBI:90942

object_name: adult liposarcoma


subject: CHEBI:90942

object_name: liposarcoma


subject: CHEBI:90942

object_name: pediatric liposarcoma


subject: CHEBI:90942

object_name: Ewing sarcoma


subject: CHEBI:90942

object_name: malignant peripheral nerve sheath tumor


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: UMLS:C0062527

subject_name: Engerix-B

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C0062527

object_name: Immunization reaction


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: childhood kidney cell carcinoma


subject: CHEBI:72317

object_name: renal carcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UNII:PJX9GH268R

object_name: Well adult


subject: UMLS:C5854409

subject_name: Ruxoprubart

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: coronary artery disorder


subject: UNII:19FUJ2C58T

object_name: coronary atherosclerosis


subject: UNII:19FUJ2C58T

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:155543961

object_name: Presenile dementia


subject: PUBCHEM.COMPOUND:155543961

object_name: dementia


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: HIV infection


subject: CHEBI:145795


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:8107

subject_name: Phenytoin


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: Pain, Procedural


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: Post-Dural Puncture Headaches


subject: CHEBI:32139

object_name: sickle cell disease


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:22652

object_name: Fatigue


subject: CHEBI:16118

subject_name: Berberine

object_name: Peptic Ulcer


subject: CHEBI:16118

object_name: gastritis


subject: CHEBI:16118

object_name: Gastritis, CTCAE


subject: CHEBI:16118

object_name: dyspepsia


subject: CHEBI:16118

object_name: Dyspepsia, CTCAE


subject: UMLS:C1828559

subject_name: GARCINIA MANGOSTANA Preparation

object_name: morbid obesity


subject: UMLS:C1828559

object_name: Class 3 Obesity


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: diffuse large B-cell lymphoma


subject: CHEBI:91872

object_name: stage I adult soft tissue sarcoma


subject: CHEBI:91872

object_name: stage II adult soft tissue sarcoma


subject: CHEBI:91872

object_name: Stage IV adult soft tissue sarcoma


subject: CHEBI:91872

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:91872

object_name: nonmetastatic childhood soft tissue sarcoma


subject: CHEBI:91872

object_name: adult liposarcoma


subject: CHEBI:91872

object_name: adult fibrosarcoma


subject: CHEBI:91872

object_name: Adult Angiosarcoma


subject: CHEBI:91872

object_name: Adult Synovial Sarcoma


subject: CHEBI:91872

object_name: dermatofibrosarcoma protuberans


subject: CHEBI:91872

object_name: pediatric liposarcoma


subject: CHEBI:91872

object_name: adult malignant schwannoma


subject: CHEBI:91872

object_name: pediatric fibrosarcoma


subject: CHEBI:91872

object_name: pediatric angiosarcoma


subject: CHEBI:91872

object_name: adult epithelioid sarcoma


subject: CHEBI:91872

object_name: Childhood Synovial Sarcoma


subject: CHEBI:91872

object_name: alveolar soft part sarcoma


subject: CHEBI:91872

object_name: childhood epithelioid sarcoma


subject: CHEBI:91872

object_name: childhood malignant schwannoma


subject: CHEBI:91872

object_name: adult extraskeletal osteosarcoma


subject: CHEBI:91872

object_name: adult myxoid chondrosarcoma


subject: CHEBI:91872

object_name: undifferentiated pleomorphic sarcoma


subject: CHEBI:91872

object_name: adult malignant hemangiopericytoma


subject: CHEBI:91872

object_name: childhood malignant mesenchymoma


subject: CHEBI:91872

object_name: adult malignant mesenchymoma


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: stage I adult soft tissue sarcoma


subject: CHEBI:28748

object_name: stage II adult soft tissue sarcoma


subject: CHEBI:28748

object_name: Stage IV adult soft tissue sarcoma


subject: CHEBI:28748

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:28748

object_name: nonmetastatic childhood soft tissue sarcoma


subject: CHEBI:28748

object_name: adult liposarcoma


subject: CHEBI:28748

object_name: adult fibrosarcoma


subject: CHEBI:28748

object_name: Adult Angiosarcoma


subject: CHEBI:28748

object_name: Adult Synovial Sarcoma


subject: CHEBI:28748

object_name: dermatofibrosarcoma protuberans


subject: CHEBI:28748

object_name: pediatric liposarcoma


subject: CHEBI:28748

object_name: adult malignant schwannoma


subject: CHEBI:28748

object_name: pediatric fibrosarcoma


subject: CHEBI:28748

object_name: pediatric angiosarcoma


subject: CHEBI:28748

object_name: adult epithelioid sarcoma


subject: CHEBI:28748

object_name: Childhood Synovial Sarcoma


subject: CHEBI:28748

object_name: alveolar soft part sarcoma


subject: CHEBI:28748

object_name: childhood epithelioid sarcoma


subject: CHEBI:28748

object_name: childhood malignant schwannoma


subject: CHEBI:28748

object_name: adult extraskeletal osteosarcoma


subject: CHEBI:28748

object_name: adult myxoid chondrosarcoma


subject: CHEBI:28748

object_name: undifferentiated pleomorphic sarcoma


subject: CHEBI:28748

object_name: adult malignant hemangiopericytoma


subject: CHEBI:28748

object_name: childhood malignant mesenchymoma


subject: CHEBI:28748

object_name: adult malignant mesenchymoma


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: stage I adult soft tissue sarcoma


subject: CHEBI:5864

object_name: stage II adult soft tissue sarcoma


subject: CHEBI:5864

object_name: Stage IV adult soft tissue sarcoma


subject: CHEBI:5864

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:5864

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:5864

object_name: Adult Leiomyosarcoma


subject: CHEBI:5864

object_name: nonmetastatic childhood soft tissue sarcoma


subject: CHEBI:5864

object_name: Childhood Leiomyosarcoma


subject: CHEBI:5864

object_name: adult liposarcoma


subject: CHEBI:5864

object_name: adult fibrosarcoma


subject: CHEBI:5864

object_name: Adult Angiosarcoma


subject: CHEBI:5864

object_name: Adult Synovial Sarcoma


subject: CHEBI:5864

object_name: dermatofibrosarcoma protuberans


subject: CHEBI:5864

object_name: pediatric liposarcoma


subject: CHEBI:5864

object_name: adult malignant schwannoma


subject: CHEBI:5864

object_name: pediatric fibrosarcoma


subject: CHEBI:5864

object_name: pediatric angiosarcoma


subject: CHEBI:5864

object_name: adult epithelioid sarcoma


subject: CHEBI:5864

object_name: Childhood Synovial Sarcoma


subject: CHEBI:5864

object_name: alveolar soft part sarcoma


subject: CHEBI:5864

object_name: childhood epithelioid sarcoma


subject: CHEBI:5864

object_name: childhood malignant schwannoma


subject: CHEBI:5864

object_name: adult extraskeletal osteosarcoma


subject: CHEBI:5864

object_name: adult myxoid chondrosarcoma


subject: CHEBI:5864

object_name: undifferentiated pleomorphic sarcoma


subject: CHEBI:5864

object_name: adult malignant hemangiopericytoma


subject: CHEBI:5864

object_name: childhood malignant mesenchymoma


subject: CHEBI:5864

object_name: adult malignant mesenchymoma


subject: DRUGBANK:DB11009

subject_name: Quahog, unspecified

object_name: leukemia


subject: DRUGBANK:DB11009

object_name: childhood leukemia


subject: UMLS:C1550146

subject_name: Other - Substance Type

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Musculoskeletal Pain


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: maturity-onset diabetes of the young type 1


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UMLS:C0061355


subject: PUBCHEM.COMPOUND:57389748

subject_name: Linagliptin

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:57389748

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:57389748

object_name: Chronic uremia


subject: CHEBI:137064

subject_name: Galunisertib

object_name: Childhood Solid Neoplasm


subject: CHEBI:137064

object_name: Adult Solid Neoplasm


subject: CHEBI:137064

object_name: Solid Neoplasm


subject: CHEBI:137064

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:137064

object_name: Recurrent Hepatocellular Carcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C4049933

subject_name: Anesthesia substance


subject: UMLS:C4049933

object_name: Diabetes


subject: UMLS:C4049933

object_name: diabetes mellitus


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:8802


subject: CHEBI:8802


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:9130


subject: UNII:NU90V55F8I

subject_name: Sarilumab

object_name: juvenile idiopathic arthritis


subject: CHEBI:178199

subject_name: Sotorasib

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:129264140

subject_name: Brigimadlin

object_name: biliary tract cancer


subject: PUBCHEM.COMPOUND:129264140


subject: PUBCHEM.COMPOUND:129264140

object_name: bladder tumor


subject: PUBCHEM.COMPOUND:129264140

object_name: urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:129264140

object_name: urinary bladder cancer


subject: PUBCHEM.COMPOUND:129264140

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:129264140

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:129264140

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:129264140

object_name: liver carcinoma


subject: UNII:9A934ZAN94

subject_name: BRIGIMADLIN


subject: UNII:9A934ZAN94


subject: UNII:9A934ZAN94


subject: UNII:9A934ZAN94


subject: UNII:9A934ZAN94


subject: UNII:9A934ZAN94


subject: UNII:9A934ZAN94


subject: UNII:9A934ZAN94


subject: UNII:9A934ZAN94


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Cow milk allergy


subject: CHEBI:50733

object_name: Breastfeeding (mother)


subject: CHEBI:50733

object_name: Neonatal hypoglycemia


subject: CHEBI:50733

object_name: Mental health issue


subject: CHEBI:8802

object_name: sleep apnea


subject: CHEBI:8802

object_name: obstructive sleep apnea syndrome


subject: CHEBI:4445

subject_name: Desflurane


subject: CHEBI:4445


subject: PUBCHEM.COMPOUND:3367

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:91508

subject_name: Racecadotril

object_name: diarrhea


subject: CHEBI:91508

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:91508

object_name: Diarrhea, CTCAE


subject: MESH:C000625007

object_name: malaria


subject: UNII:J0IIT8QSQS

subject_name: Galicaftor

object_name: cystic fibrosis


subject: UNII:W2F2XU189O

subject_name: NAVOCAFTOR


subject: DRUGBANK:DB19039

subject_name: Navocaftor


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Clinical Stage III Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Clinical Stage II Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Clinical Stage I Esophageal Adenocarcinoma AJCC v8


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: DRUGBANK:DB18646

object_name: Low Risk Myelodysplastic Syndrome


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Leptomeningeal Neoplasms


subject: CHEBI:31348

object_name: neoplastic meningitis


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: UNII:234248D0HH


subject: UMLS:C5854406

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: acute chest syndrome


subject: UMLS:C2825026

object_name: sickle cell disease


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:151315


subject: CHEBI:33704

subject_name: Amino acid

object_name: kidney failure


subject: CHEBI:33704

object_name: Renal Failure, CTCAE


subject: UMLS:C0002520

subject_name: Amino Acids


subject: UMLS:C0002520


subject: UMLS:C2917660

subject_name: Amino Acid [EPC]


subject: UMLS:C2917660


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Ischemic reperfusion injury


subject: CHEBI:6888

object_name: hepatic; insufficiency, postoperative


subject: CHEBI:6888

object_name: liver neoplasm


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939


subject: GTOPDB:13869

object_name: adult-onset Still disease


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: mucositis


subject: CHEBI:22198

object_name: tongue cancer


subject: CHEBI:22198

object_name: tongue carcinoma


subject: CHEBI:22198

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:22198

object_name: Salivary gland cancer stage I


subject: CHEBI:22198

object_name: Stage I Major Salivary Gland Cancer AJCC v7


subject: CHEBI:22198

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:22198

object_name: stage IVA salivary gland cancer


subject: CHEBI:22198

object_name: Stage II Major Salivary Gland Cancer AJCC v7


subject: CHEBI:22198

object_name: Salivary gland cancer stage II


subject: CHEBI:22198

object_name: stage IVC salivary gland cancer


subject: CHEBI:22198

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:22198

object_name: Salivary gland cancer stage III


subject: CHEBI:22198

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: CHEBI:22198

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:22198

object_name: stage IVB salivary gland cancer


subject: CHEBI:22198

object_name: Oral Complication


subject: CHEBI:22198

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:22198

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:22198

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:22198

object_name: Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: stage IVA mucoepidermoid carcinoma of the oral cavity


subject: CHEBI:22198

object_name: Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: stage IVA adenoid cystic carcinoma of the oral cavity


subject: CHEBI:22198

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:22198

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:22198

object_name: Mucoepidermoid carcinoma of the oral cavity stage I


subject: CHEBI:22198

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:22198

object_name: Mucoepidermoid carcinoma of the oral cavity stage II


subject: CHEBI:22198

object_name: Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: stage IVB mucoepidermoid carcinoma of the oral cavity


subject: CHEBI:22198

object_name: Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: stage IVC mucoepidermoid carcinoma of the oral cavity


subject: CHEBI:22198

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: CHEBI:22198

object_name: Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:22198

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:22198

object_name: Verrucous carcinoma of the oral cavity stage I


subject: CHEBI:22198

object_name: Verrucous carcinoma of the oral cavity stage II


subject: CHEBI:22198

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:22198

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:22198

object_name: Verrucous carcinoma of the oral cavity stage III


subject: CHEBI:22198

object_name: Adenoid cystic carcinoma of the oral cavity stage I


subject: CHEBI:22198

object_name: Adenoid cystic carcinoma of the oral cavity stage II


subject: CHEBI:22198

object_name: stage IVC adenoid cystic carcinoma of the oral cavity


subject: CHEBI:22198

object_name: Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: stage IVB adenoid cystic carcinoma of the oral cavity


subject: CHEBI:22198

object_name: Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: CHEBI:22198

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:22198


subject: CHEBI:22198

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:22198

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:22198

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:22198

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:22198

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:22198

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:22198

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:22198

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:22198

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:22198

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:22198

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: CHEBI:22198

object_name: stage IVA lymphoepithelioma of the oropharynx


subject: CHEBI:22198

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: CHEBI:22198

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: CHEBI:22198

object_name: Nasopharyngeal squamous cell carcinoma stage II


subject: CHEBI:22198

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:22198

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:22198

object_name: stage IVA squamous cell carcinoma of the larynx


subject: CHEBI:22198

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:22198

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:22198

object_name: stage IVA verrucous carcinoma of the larynx


subject: CHEBI:22198

object_name: stage IVC lymphoepithelioma of the oropharynx


subject: CHEBI:22198

object_name: Oropharyngeal lymphoepithelioma stage III


subject: CHEBI:22198

object_name: stage IVB lymphoepithelioma of the oropharynx


subject: CHEBI:22198

object_name: Nasopharyngeal squamous cell carcinoma stage I


subject: CHEBI:22198

object_name: Oropharyngeal lymphoepithelioma stage II


subject: CHEBI:22198

object_name: Oropharyngeal lymphoepithelioma stage I


subject: CHEBI:22198

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:22198

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:22198

object_name: stage IVC squamous cell carcinoma of the larynx


subject: CHEBI:22198

object_name: stage IVB squamous cell carcinoma of the larynx


subject: CHEBI:22198

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:22198

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:22198

object_name: stage IVC verrucous carcinoma of the larynx


subject: CHEBI:22198

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:22198

object_name: stage IVB verrucous carcinoma of the larynx


subject: CHEBI:22198

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: Laryngeal verrucous carcinoma stage III


subject: CHEBI:22198

object_name: Laryngeal squamous cell carcinoma stage II


subject: CHEBI:22198

object_name: Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: CHEBI:22198

object_name: Laryngeal verrucous carcinoma stage II


subject: CHEBI:22198

object_name: Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:22198

object_name: Nasopharyngeal lymphoepithelioma stage II


subject: CHEBI:22198

object_name: Laryngeal squamous cell carcinoma stage I


subject: CHEBI:22198

object_name: Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: Stage IVA Basal Cell Lip Carcinoma


subject: CHEBI:22198

object_name: Laryngeal verrucous carcinoma stage I


subject: CHEBI:22198

object_name: Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:22198

object_name: Nasopharyngeal lymphoepithelioma stage I


subject: CHEBI:22198

object_name: Stage III Lip Basal Cell Carcinoma


subject: CHEBI:22198

object_name: Stage IVB Basal Cell Lip Carcinoma


subject: CHEBI:22198

object_name: Stage IVC Basal Cell Lip Carcinoma


subject: CHEBI:22198

object_name: Stage II Lip Basal Cell Carcinoma


subject: CHEBI:22198

object_name: Stage I Lip Basal Cell Carcinoma


subject: CHEBI:28939

object_name: tongue cancer


subject: CHEBI:28939

object_name: tongue carcinoma


subject: CHEBI:28939

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:28939

object_name: Salivary gland cancer stage I


subject: CHEBI:28939

object_name: Stage I Major Salivary Gland Cancer AJCC v7


subject: CHEBI:28939

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:28939

object_name: stage IVA salivary gland cancer


subject: CHEBI:28939

object_name: Stage II Major Salivary Gland Cancer AJCC v7


subject: CHEBI:28939

object_name: Salivary gland cancer stage II


subject: CHEBI:28939

object_name: stage IVC salivary gland cancer


subject: CHEBI:28939

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:28939

object_name: Salivary gland cancer stage III


subject: CHEBI:28939

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: CHEBI:28939

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:28939

object_name: stage IVB salivary gland cancer


subject: CHEBI:28939

object_name: Oral Complication


subject: CHEBI:28939

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:28939

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:28939

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:28939

object_name: Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: stage IVA mucoepidermoid carcinoma of the oral cavity


subject: CHEBI:28939

object_name: Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: stage IVA adenoid cystic carcinoma of the oral cavity


subject: CHEBI:28939

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:28939

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:28939

object_name: Mucoepidermoid carcinoma of the oral cavity stage I


subject: CHEBI:28939

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:28939

object_name: Mucoepidermoid carcinoma of the oral cavity stage II


subject: CHEBI:28939

object_name: Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: stage IVB mucoepidermoid carcinoma of the oral cavity


subject: CHEBI:28939

object_name: Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: stage IVC mucoepidermoid carcinoma of the oral cavity


subject: CHEBI:28939

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: CHEBI:28939

object_name: Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:28939

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:28939

object_name: Verrucous carcinoma of the oral cavity stage I


subject: CHEBI:28939

object_name: Verrucous carcinoma of the oral cavity stage II


subject: CHEBI:28939

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:28939

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:28939

object_name: Verrucous carcinoma of the oral cavity stage III


subject: CHEBI:28939

object_name: Adenoid cystic carcinoma of the oral cavity stage I


subject: CHEBI:28939

object_name: Adenoid cystic carcinoma of the oral cavity stage II


subject: CHEBI:28939

object_name: stage IVC adenoid cystic carcinoma of the oral cavity


subject: CHEBI:28939

object_name: Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: stage IVB adenoid cystic carcinoma of the oral cavity


subject: CHEBI:28939

object_name: Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: CHEBI:28939

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:28939


subject: CHEBI:28939

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:28939

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:28939

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:28939

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:28939

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:28939

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:28939

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:28939

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:28939

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:28939

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:28939

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: CHEBI:28939

object_name: stage IVA lymphoepithelioma of the oropharynx


subject: CHEBI:28939

object_name: Oropharyngeal squamous cell carcinoma stage I